Dfmo And Celecoxib In Combination For Cancer Chemoprevention And Therapy

Abstract

Celecoxib, a COX-2 specific non-steroidal anti-inflammatory agent, is provided in combination with DFMO for the prevention and/or treatment of cancers. Provided with the present invention are pharmaceutically acceptable compositions that include a non-steroidal anti-inflammatory agent, celecoxib, together with an effective amount of difluoromethylornithine.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Jun 3, 2003
  • Application: May 17, 2000
    US US 57308900 A
  • Priority: May 17, 2000
    US US 57308900 A
  • Priority: May 17, 1999
    US US 13458299 P

Download Citation


Sign in to the Lens

Feedback